Real-time enrollment status for this congenital adrenal hyperplasia clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 9:07 PM UTC
| NCT Number | NCT07144163 |
| Recruiting Status | Recruiting |
| Condition | Congenital Adrenal Hyperplasia |
| Phase | PHASE3 |
| Target Enrollment | 150 participants |
| Active Locations | 12 sites in the US |
| Sponsor | Crinetics Pharmaceuticals Inc. |
| Last Updated on CT.gov | August 12, 2026 (2 weeks ago) |
As of August 27, 2026: Clinical trial NCT07144163 is currently recruiting participants. This phase3 study for congenital adrenal hyperplasia is actively seeking new participants at 12 locations across the United States. The study is sponsored by Crinetics Pharmaceuticals Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07144163 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07144163 was last updated 2 weeks ago (August 12, 2026). HelloStudys verifies this status automatically.